Literature DB >> 8815750

Rapid, solid phase extraction technique for the high-throughput assay of darifenacin in human plasma.

B Kaye1, W J Herron, P V Macrae, S Robinson, D A Stopher, R F Venn, W Wild.   

Abstract

A novel method has been developed for the rapid solid phase extraction of drugs and metabolites from biological fluids, prior to further analysis. The newly designed, 96-tube micropreparation block facilitates high throughput by enabling the extraction of 96 samples simultaneously. The system is described, linked to HPLC/APCI-MS/MS, for the determination of darifenacin in human plasma. The resulting procedure, using deuterated darifenacin as internal standard, is validated over the concentration range 25-2000 pg/mliter; accuracy (0.6-4.6%) and precision (3.6-18.8%) are considered acceptable and overall recovery was determined to be approximately 50%.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815750     DOI: 10.1021/ac9507552

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  5 in total

1.  High-throughput sample preparation and analysis using 96-well membrane solid-phase extraction and liquid chromatography-tandem mass spectrometry for the determination of steroids in human urine.

Authors:  G Rule; J Henion
Journal:  J Am Soc Mass Spectrom       Date:  1999-12       Impact factor: 3.109

2.  Assessment of the relative in vivo potency of the hydroxylated metabolite of darifenacin in its ability to decrease salivary flow using pooled population pharmacokinetic-pharmacodynamic data.

Authors:  Thomas Kerbusch; Peter A Milligan; Mats O Karlsson
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

Review 3.  The clinical pharmacokinetics of darifenacin.

Authors:  Andrej Skerjanec
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulation-dependent bioavailability.

Authors:  Thomas Kerbusch; Ulrika Wählby; Peter A Milligan; Mats O Karlsson
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

5.  Benzylic C-H acylation by cooperative NHC and photoredox catalysis.

Authors:  Qing-Yuan Meng; Lena Lezius; Armido Studer
Journal:  Nat Commun       Date:  2021-04-06       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.